BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 26455529)

  • 1. The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection.
    Adami AJ; Cervantes JL
    Tuberculosis (Edinb); 2015 Dec; 95(6):651-658. PubMed ID: 26455529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination.
    Cohen SB; Gern BH; Delahaye JL; Adams KN; Plumlee CR; Winkler JK; Sherman DR; Gerner MY; Urdahl KB
    Cell Host Microbe; 2018 Sep; 24(3):439-446.e4. PubMed ID: 30146391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
    Gupta N; Kumar R; Agrawal B
    Front Immunol; 2018; 9():709. PubMed ID: 29692778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary.
    Grosset J
    Antimicrob Agents Chemother; 2003 Mar; 47(3):833-6. PubMed ID: 12604509
    [No Abstract]   [Full Text] [Related]  

  • 5. HDAC3 inhibitor RGFP966 controls bacterial growth and modulates macrophage signaling during Mycobacterium tuberculosis infection.
    Campo M; Heater S; Peterson GJ; Simmons JD; Skerrett SJ; Mayanja-Kizza H; Stein CM; Boom WH; Hawn TR
    Tuberculosis (Edinb); 2021 Mar; 127():102062. PubMed ID: 33639591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent Mycobacterium tuberculosis reporters: illuminating host-pathogen interactions.
    MacGilvary NJ; Tan S
    Pathog Dis; 2018 Apr; 76(3):. PubMed ID: 29718182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Mycobacterium tuberculosis Uptake by Alveolar Macrophages after Ex vivo Expansion Indicates Processing Host Cells with Pathogen Actually from Lung Tissue of Patients with Pulmonary Tuberculosis.
    Ufimtseva E; Eremeeva N; Bayborodin S; Umpeleva T; Vakhrusheva D; Skornyakov S
    Int J Mycobacteriol; 2020; 9(2):176-184. PubMed ID: 32474540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early dynamics of innate immunity during pulmonary tuberculosis.
    Corleis B; Dorhoi A
    Immunol Lett; 2020 May; 221():56-60. PubMed ID: 32092359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human microbiota in pulmonary tuberculosis: Not so innocent bystanders.
    Tarashi S; Ahmadi Badi S; Moshiri A; Nasehi M; Fateh A; Vaziri F; Siadat SD
    Tuberculosis (Edinb); 2018 Dec; 113():215-221. PubMed ID: 30514505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of microbiota in respiratory health and diseases, particularly in tuberculosis.
    Shah T; Shah Z; Baloch Z; Cui X
    Biomed Pharmacother; 2021 Nov; 143():112108. PubMed ID: 34560539
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Woo M; Wood C; Kwon D; Park KP; Fejer G; Delorme V
    Front Immunol; 2018; 9():438. PubMed ID: 29593716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis with different virulence reside within intact phagosomes and inhibit phagolysosomal biogenesis in alveolar macrophages of patients with pulmonary tuberculosis.
    Ufimtseva E; Eremeeva N; Bayborodin S; Umpeleva T; Vakhrusheva D; Skornyakov S
    Tuberculosis (Edinb); 2019 Jan; 114():77-90. PubMed ID: 30711161
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Shim D; Kim H; Shin SJ
    Front Immunol; 2020; 11():910. PubMed ID: 32477367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
    O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
    Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metagenomic analysis of the lung microbiome in pulmonary tuberculosis - a pilot study.
    Hu Y; Cheng M; Liu B; Dong J; Sun L; Yang J; Yang F; Chen X; Jin Q
    Emerg Microbes Infect; 2020 Dec; 9(1):1444-1452. PubMed ID: 32552447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium tuberculosis manipulates pulmonary APCs subverting early immune responses.
    Garcia-Romo GS; Pedroza-Gonzalez A; Lambrecht BN; Aguilar-Leon D; Estrada-Garcia I; Hernandez-Pando R; Flores-Romo L
    Immunobiology; 2013 Mar; 218(3):393-401. PubMed ID: 22749983
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Ufimtseva EG; Eremeeva NI; Umpeleva TV; Vakhrusheva DV; Skornyakov SN
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lung-on-chip model of early
    Thacker VV; Dhar N; Sharma K; Barrile R; Karalis K; McKinney JD
    Elife; 2020 Nov; 9():. PubMed ID: 33228849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The secret trumps, impelling the pathogenicity of tubercle bacilli.
    Cardona PJ; Ivanyi J
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():14-9. PubMed ID: 21420562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis cording in alveolar macrophages of patients with pulmonary tuberculosis is likely associated with increased mycobacterial virulence.
    Ufimtseva EG; Eremeeva NI; Petrunina EM; Umpeleva TV; Bayborodin SI; Vakhrusheva DV; Skornyakov SN
    Tuberculosis (Edinb); 2018 Sep; 112():1-10. PubMed ID: 30205961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.